Multiple studies have noted a strong association of STAG2 inactivation and TP53 mutation in Ewing sarcoma, whereby the combination of these two genetic alterations is significantly associated with poor prognosis relative to STAG2 and TP53 wildtype tumors24,28. The gene discussed is STAG2; the disease is Ewing sarcoma.